CLINICAL_TRIALS
trial_result
· 2015-07-01
Clinical Trial Update: Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis [Phase 4]
Summary
Phase 4 clinical trial evaluating the efficacy and safety of Shenyankangfu Tablets for primary glomerulonephritis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Chinese PLA General Hospital | Conditions: Glomerulonephritis, Proteinuria | Phase 4 | Status: UNKNOWN